Press Releases on January 11, 2021 - EIN Presswire - Press Release Distribution Service

Published on January 11, 2021 - 12:00 GMT

XPO Logistics Partners with Truckers Against Trafficking to Help Combat Human Trafficking

GREENWICH, Conn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, today announced a new partnership with Truckers Against Trafficking (TAT) to further the company’s stance against …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...

Published on January 11, 2021 - 12:00 GMT

Critically Acclaimed Spiritual Fiction Vividly Details an Atheist Woman’s Transformative Encounters at an Ordinary Garage Sale, ...

CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- What if God showed up at your garage sale to teach you about life and prove His existence? Author Dr. Marni Hill Foderaro explores this very scenario in her spiritual fiction, “God Came to My Garage Sale,” the …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Local Man Creates Handy Double-Sided Mask Clip

Handy invention is selling briskly; it solves a variety of problems with no fanfare DALLAS, Jan. 11, 2021 (GLOBE NEWSWIRE) -- In the thick of a resurgent pandemic, a local man has a new invention that is selling at an extremely fast pace. Walter Hall, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Stingray to Release its Financial Results for the Third Quarter of Fiscal 2021

MONTREAL, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Stingray Group Inc. (TSX: RAY.A; RAY.B) will release its financial results for the third quarter ended December 31, 2020, on Wednesday, February 3, 2021, after the markets close. Management will hold a conference …

Distribution channels:

Published on January 11, 2021 - 12:00 GMT

Greenlane Announces Dismissal of Class Action Suit with Prejudice

BOCA RATON, Fla., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. (“Greenlane” or "the Company”) (Nasdaq: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and …

Distribution channels: Business & Economy, Law ...

Published on January 11, 2021 - 12:00 GMT

Hopebridge Expands Leadership Team, Adds Dr. Adam Hahs

INDIANAPOLIS, Jan. 11, 2021 (GLOBE NEWSWIRE) -- One of the largest autism therapy healthcare providers in the nation, Hopebridge Autism Therapy Centers, announced today the addition of Dr. Adam Hahs to the company’s leadership team. Serving as vice …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021

BURLINGAME, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today provided a corporate update and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of AMDX-2011P, a First-in-Class Retinal ...

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye, today announced successful completion of pre-IND ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term ...

– Company Expects to File for Regulatory Approval for Mitapivat for the Treatment of Adults with Pyruvate Kinase (PK) Deficiency in the U.S. in Q2 2021 and in the EU in Mid-2021 – – Pivotal Trials for Mitapivat in Thalassemia on Track for Initiation in 2H …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with ...

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 11, 2021 - 12:00 GMT

Destination XL Group, Inc. Holiday Sales Results and Guidance

CANTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (OTCQX:DXLG), the largest omni-channel specialty retailer of big and tall men's apparel, today announced the following results for the 9-week holiday sales period ended January …

Distribution channels: Media, Advertising & PR, Textiles & Fabric Industry ...

Published on January 11, 2021 - 12:00 GMT

Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021

– Investigational New Drug Applications (IND) submitted for PBFT02 for Frontotemporal Dementia with Granulin Mutation (FTD-GRN) and PBKR03 for Krabbe Disease – – Three clinical programs to begin in 1H21 – – Metachromatic leukodystrophy program, PBML04, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19

LONDON and MONTREAL, Jan. 11, 2021 (GLOBE NEWSWIRE) -- DalCor Pharmaceuticals today announced the initiation of dal-COVID, a Phase 2 proof-of-concept study for dalcetrapib as a potential oral anti-viral treatment for COVID-19. The main protease (3CLMpro) …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost

PURCHASE, NY and SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 11, 2021 - 12:00 GMT

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020

ALACHUA, Fla., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2020 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

MediWound Provides Progress Update on Its EscharEx Clinical Development Program

Phase 2 Adaptive Design Study Sample Size Reduced to 120 Patients Interim Assessment Expected in Mid-2021 and Completion of Enrollment by Year-End 2021 Protocol Submitted to FDA for Pharmacology Clinical Study with Data Expected in Second Half 2021 YAVNE, …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 11, 2021 - 12:00 GMT

Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory ...

The Resonate™ program provides access to a potential genetic diagnosis by offering genetic testing at no cost to eligible individuals, their insurance, or their healthcare providers A genetic diagnosis may help individuals and their healthcare providers …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 11, 2021 - 12:00 GMT

Travere Therapeutics Provides Corporate Update and 2021 Outlook

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects net product sales for the fourth quarter of 2020 to be approximately $51 million. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 11, 2021 - 12:00 GMT

Clarity Gold Advances Option to Acquire Destiny Project

VANCOUVER, British Columbia, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Clarity Gold Corp. (“Clarity” or the “Company”) (CSE: CLAR, OTC: CLGCF, FSE: 27G) is pleased to announce that all of the conditions precedent set forth in the previously announced option …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on January 11, 2021 - 12:00 GMT

Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem ...

Preparations on Track for First Half 2021 Commercial Launch of Libmeldy™ (OTL-200), the First Approved Product for Metachromatic Leukodystrophy (MLD) in the EU Filing Strategy for OTL-200 Biologics License Application (BLA) in MLD in the U.S. to be …

Distribution channels: